PeptiDatabase — peptit haberleri https://peptidatabase.com/tr/haberler/ Kataloğumuzdaki peptitler ve genel olarak peptitler hakkında, dünyanın dört bir yanından resmi kurum duyuruları ve sağlık haberleri; her biri asıl kaynağına bağlantılı. Üçüncü taraf içeriğidir. Başlıklar özgün dilinde gösterilir ve yayıncıya bağlanır; bağlantı vermek onaylamak anlamına gelmez. Buradaki hiçbir bilgi tıbbi tavsiye değildir. tr HHS to allow compounders to make 6 unapproved peptideshttps://www.biopharmadive.com/news/hhs-peptides-rfk-fda-compounders/873141/peptidatabase-news-40b4ec8a96deThu, 29 Oct 2026 14:52:00 GMTBioPharma Dive STAT+: El-Sayed claps back at RFK Jr., and FDA’s ‘enforcement discretion’ on peptideshttps://www.statnews.com/2026/10/29/el-sayed-claps-back-at-rfk-jr-fda-peptide-policy-dc-diagnosis/?utm_campaign=rsspeptidatabase-news-1389b6f3b03aThu, 29 Oct 2026 14:18:27 GMTSTAT STAT+: HHS green lights six peptides, despite concerns from FDA scientistshttps://www.statnews.com/2026/10/29/biotech-news-hhs-green-lights-six-peptides-for-now/?utm_campaign=rsspeptidatabase-news-cf9e11e80f18Thu, 29 Oct 2026 13:43:44 GMTSTAT STAT+: Pharmalittle: We’re reading about a new policy for compounding peptides, a PBM disclosure rule, and morehttps://www.statnews.com/pharmalot/2026/10/29/peptides-policy-released-by-hhs-pbm-disclosure-requirements/?utm_campaign=rsspeptidatabase-news-5c2a4aa1f6e5Thu, 29 Oct 2026 12:52:11 GMTSTAT STAT+: HHS moves to allow compounding of some unapproved peptideshttps://www.statnews.com/2026/10/28/hhs-enforcement-discretion-policy-allows-peptide-compounding/?utm_campaign=rsspeptidatabase-news-55a064f90f11Wed, 28 Oct 2026 16:35:03 GMTSTAT · Pharma Lilly’s ‘triple-G’ drug tops Novo’s Ozempic in diabetes trialhttps://www.biopharmadive.com/news/retatrutide-ozempic-diabetes-trial-results-lilly-novo/873016/peptidatabase-news-2e94f5600e7cWed, 28 Oct 2026 15:53:00 GMTBioPharma DiveRetatrutideSemaglutide STAT+: Lilly’s triple-G drug beats Ozempic in head-to-head studyhttps://www.statnews.com/2026/10/28/biotech-news-lillys-triple-g-drug-beats-ozempic-in-head-to-head-study/?utm_campaign=rsspeptidatabase-news-d689844cf2d2Wed, 28 Oct 2026 13:42:44 GMTSTAT · PharmaRetatrutideSemaglutide STAT+: Lilly says ‘triple-G’ drug beat Novo’s Ozempic in diabetes studyhttps://www.statnews.com/2026/10/28/retatrutide-vs-ozempic-lilly-diabetes-study/?utm_campaign=rsspeptidatabase-news-3266f8049cbdWed, 28 Oct 2026 10:45:00 GMTSTAT · PharmaSemaglutide Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 October 2026https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-12-15-october-2026peptidatabase-news-4d422aed881fFri, 16 Oct 2026 10:00:00 GMTEMA · News and press releasesKurumun özeti (EMA): Six new medicines recommended for approvalEMA’s human medicines committee (CHMP) recommended six medicines for approval at its October 2026 meeting. Rasonque (daraxonrasib)…OrforglipronSemaglutide Greenwich Rx Issues Voluntary Nationwide Recall of Compounded Glutathione Due to Elevated Endotoxin Levelshttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/greenwich-rx-issues-voluntary-nationwide-recall-compounded-glutathione-due-elevated-endotoxin-levelspeptidatabase-news-c28baaf9065bThu, 01 Oct 2026 04:00:00 GMTFDA · MedWatch safety alertsGlutathione